Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

AAN 2022 | Future work on pharmacogenomic testing in migraine

Yi-Chieh Chen • 5 Apr 2022
AAN 2022
Headache Verapamil

Yi-Chieh Chen, PharmD, Mayo Clinic, Rochester, MN, discusses future work concerning verapamil and pharmacogenomics in treating migraine. Pharmacogenomic testing is far more common in anti-depressants than in migraine-specific therapies. Since many anti-depressants are also used for the preventive treatment of migraine, future work would investigate the pharmacogenomic effects of anti-depressants to produce a larger sample size. This interview took place at the American Academy of Neurology 2022 Congress in Seattle, WA.

More from Yi-Chieh Chen

Personalized treatment in migraine prevention
1:48
Personalized treatment in migraine prevention
Yi-Chieh Chen • 5 Apr 2022
A pilot study of the effect of pharmacogenomic data on dosages of verapamil for migraine prevention
4:46
A pilot study of the effect of pharmacogenomic data on dosages of verapamil for migraine prevention
Yi-Chieh Chen • 5 Apr 2022
The promise of pharmacogenomics in migraine
1:34
The promise of pharmacogenomics in migraine
Yi-Chieh Chen • 9 Jun 2022
Pharmacogenomics in medicine and migraine treatment
2:51
Pharmacogenomics in medicine and migraine treatment
Yi-Chieh Chen • 9 Jun 2022

Related Videos

PACAP-38 is increased in the tear fluid of patients with migraine
1:50
PACAP-38 is increased in the tear fluid of patients with migraine
Marina Romozzi • 27 Jun 2026
TRIPLE study: triple combination therapy for chronic migraine
2:41
TRIPLE study: triple combination therapy for chronic migraine
Marina Romozzi • 27 Jun 2026
Combination therapy for migraine: anti-CGRP, anti-PACAP, and onabotulinumtoxinA
8:49
Combination therapy for migraine: anti-CGRP, anti-PACAP, and onabotulinumtoxinA
Richard Lipton • 1 Jul 2026
RESOLUTION: eptinezumab and patient education for chronic migraine and medication-overuse headache
6:48
RESOLUTION: eptinezumab and patient education for chronic migraine and medication-overuse headache
Richard Lipton • 1 Jul 2026

Choose your cookie settings

VJNeurology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJNeurology is intended for healthcare professionals